Sponsor
1 Reduction of Stent Thrombosis in Patients with Acute Coronary Syndrome Treated with Rivaroxaban in ATLAS ACS 2-TIMI 51 JACC - Journal of the American College of Cardiology, April 26, 2013
2 The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation Platelets, April 19, 2013
3 Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease International Journal of Cardiology, April 22, 2013
4 Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy American Heart Journal, April 30, 2013
5 Anaesthetic techniques to prevent perioperative stroke Current Opinion in Anesthesiology, May 10, 2013 Review Article
6 Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature Lupus, April 25, 2013
7 Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II European Heart Journal, April 30, 2013 Review Article
8 Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with anti-platelet therapy Catheterization and Cardiovascular Interventions, May 1, 2013
9 Carotid artery stenting: Patient, lesion, and procedural characteristics that increase procedural complications Catheterization and Cardiovascular Interventions, May 1, 2013
10 Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia Cochrane Reviews, May 9, 2013 Evidence Based Medicine
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor